Literature DB >> 19452137

[Differential diagnosis of condylomata acuminata. Indication for histopathology].

G Gross1.   

Abstract

Condylomata acuminata are the most frequently diagnosed sexually transmitted disease of the anogenital area worldwide. The basis of successful therapy is the correct diagnosis. There are numerous differential diagnostic considerations, many of which can only be confirmed with histological examination. The diagnosis and differential diagnosis of condylomata acuminata is reviewed. Combining histologic evaluation into the diagnostic approach should improve the therapeutic results.

Entities:  

Mesh:

Year:  2009        PMID: 19452137     DOI: 10.1007/s00105-008-1694-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  23 in total

1.  European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts.

Authors:  G von Krogh; C J Lacey; G Gross; R Barrasso; A Schneider
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

2.  Sexually transmitted infections in New Zealand in 2003.

Authors:  Alisha Johnston; Dinusha Fernando; Graham MacBride-Stewart
Journal:  N Z Med J       Date:  2005-03-11

3.  Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination.

Authors:  Pierre Vandepapeliere; Renzo Barrasso; Chris J L M Meijer; Jan M M Walboomers; Martine Wettendorff; Lawrence R Stanberry; Charles J N Lacey
Journal:  J Infect Dis       Date:  2005-11-11       Impact factor: 5.226

4.  Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis.

Authors:  Lisa E Manhart; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2002-11       Impact factor: 2.830

Review 5.  Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.

Authors:  Charles J N Lacey; Catherine M Lowndes; Keerti V Shah
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

Review 6.  Therapy for genital human papillomavirus-related disease.

Authors:  Charles J N Lacey
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

Review 7.  [What does HPV vaccination mean for gynecologic cancer screening?].

Authors:  K U Petry
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

Review 8.  [Impact of prophylactic HPV vaccines on dermatology and venereology].

Authors:  G Gross
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

9.  The health and economic burden of genital warts in a set of private health plans in the United States.

Authors:  Ralph P Insinga; Erik J Dasbach; Evan R Myers
Journal:  Clin Infect Dis       Date:  2003-05-19       Impact factor: 9.079

10.  Papillomavirus infection of the anogenital region: correlation between histology, clinical picture, and virus type. Proposal of a new nomenclature.

Authors:  G Gross; H Ikenberg; L Gissmann; M Hagedorn
Journal:  J Invest Dermatol       Date:  1985-08       Impact factor: 8.551

View more
  4 in total

1.  Anogenital Warts in Childhood - Always a Marker for Sexual Abuse?

Authors:  S Bussen; M Sütterlin; U Schmidt; D Bussen
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-01       Impact factor: 2.915

Review 2.  [Anogenital warts and HPV-associated precancers : Looking into the recently passed German S2k guideline].

Authors:  P Schneede; B Schlenker
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

3.  [Conservative treatment of anogenital HPV infections].

Authors:  G Gross
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

Review 4.  Clinical and pathological aspects of condyloma acuminatum - review of literature and case presentation.

Authors:  Damian Diţescu; Anca Maria Istrate-Ofiţeru; Gabriela Camelia Roşu; Larisa Iovan; Ilona Mihaela Liliac; George Lucian Zorilă; Maria Bălăşoiu; Liliana Cercelaru
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.